RocketTickers

FDA Grants QIDP and Fast Track Designations

Long
NASDAQ:CDTX   Cidara Therapeutics, Inc.
CDTX: Cidara Therapeutics, Inc.
2018-09-25 08:00:00
FDA Grants QIDP and Fast Track Designations to Cidara Therapeutics’ Rezafungin Prophylaxis Development Program
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.